首页> 外文会议>World congress on medical physics and biomedical engineering >Use of Nanoparticles in Brachytherapy - An Alternative for Enhancing Doses in Cancer Treatment
【24h】

Use of Nanoparticles in Brachytherapy - An Alternative for Enhancing Doses in Cancer Treatment

机译:在近距离放射治疗中使用纳米颗粒 - 一种增强癌症治疗剂量的替代方案

获取原文

摘要

The aim of this study is to demonstrate that the use of gold nanoparticles may enhance the dose in the tumour cells during brachytherapy. A Monte Carlo transport code, MCNPX was used to estimate this dose enhancement. The high-intensity 192Ir source design, for high dose-rate (HDR) brachytherapy is used in the simulation. The l92Ir source was located at the uterus phantom proposed by Eckerman and Cristy, 1996. The current study considered three levels of gold nanoparticles concentration within the tumour: 7, 18 and 30 mg Au/g tissue assuming no presence of gold outside the tumour. The dose enhancement factor for gold nanoparticles within the tumour region ranged from 5% to 20% depending on the radial distance from the source and the gold concentration level within the tumour. It is concluded that the use of nanoparticles like Au are promising in the brachytherapy treatment because of high effectiveness for the enhancing of doses within the tumour cells. This enhancing effect has a substantial advantage in reducing the number of daily fractions of radiation in the tumour, compared with the conventional treatment.
机译:本研究的目的是证明金纳米颗粒的使用可以在近距离放射治疗期间增强肿瘤细胞中的剂量。 MCNPX的蒙特卡罗传输代码用于估计这种剂量增强。在模拟中使用高强度192ir源设计,用于高剂量率(HDR)近距离放射治疗。 L92IR源位于Eckerman和Cristy,1996年提出的Uterus Phantom。目前的研究认为肿瘤内的三个水平的金纳米颗粒浓度:7,18和30mg Au / g组织假设在肿瘤外没有存在金。肿瘤区域内金纳米颗粒的剂量增强因子根据源源和肿瘤内的金浓度水平的径向距离为5%至20%。结论是,由于肿瘤细胞内剂量的增强,纳米颗粒如Au的使用在近距离放射治疗中的使用。与常规治疗相比,这种增强效果在减少肿瘤中的每日辐射的数量方面具有显着优势。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号